Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression
| Autor: | Obermannová, R. *, Van Cutsem, E., Yoshino, T., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., Garcia Alfonso, P., Portnoy, D., Cohn, A., Yamazaki, K., Clingan, P., Lonardi, S., Kim, T.W., Yang, L., Nasroulah, F., Tabernero, J. |
|---|---|
| Zdroj: | In Annals of Oncology November 2016 27(11):2082-2089 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|